CALLIDITAS THERAPEUTICS AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 103.7 SEK | -0.38% |
|
+3.18% | -18.41% |
Chart calendar Calliditas Therapeutics AB
a50f74e297272e5fd3b8e4efe.uDbpcDnvj0YlD6L9EEnUil5Ob6mHHkxN-YzyBibW-rc.i2OtOlGhxAtNa9qRQDG6vWgZPNy1aSoKgMiXZEiFu-7vfoIpY6jqLVdO7w~f92073011a85ae507f4bcb6269f6a806
Upcoming events on Calliditas Therapeutics AB
Past events on Calliditas Therapeutics AB
| 24/04/2024 | World Orphan Drug Congress |
| 15/04/2024 | Van Lanschot Kempen Life Sciences Conference |
| 15/04/2024 17:45 | ISN World Congress - Evolving Landscape of eGFR |
| 14/04/2024 21:45 | ISN World Congress - Poster No: SUN-037 |
| 14/04/2024 21:45 | ISN World Congress - Poster No: SUN-036 |
| 14/04/2024 21:45 | ISN World Congress - Poster No: SUN-050 |
| 14/04/2024 21:45 | ISN World Congress - Poster No: SUN-034 |
| 12/03/2024 | Jefferies Biotech on the Bay Summit |
| 11/03/2024 | Leerink Partners Global Biopharma Conference |
| 06/03/2024 09:20 | Carnegie Healthcare Conference |
| 21/02/2024 13:30 | Q4 2023 Earnings Call |
| 21/02/2024 06:43 | Q4 2023 Earnings Release |
| 08/02/2024 16:00 | Guggenheim Healthcare Talks Biotechnology Conference |
| 09/01/2024 15:30 | JPMorgan Healthcare Conference |
| 27/11/2023 | Piper Sandler Healthcare Conference |
| 20/11/2023 | SEB Healthcare Seminar |
| 15/11/2023 15:10 | Stifel Healthcare Conference - Fireside Chat |
| 15/11/2023 14:00 | Jefferies London Healthcare Conference |
| 08/11/2023 11:05 | FT Global Pharma & Biotech Summit - Panel |
| 07/11/2023 13:30 | Q3 2023 Earnings Call |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 0,00 0,00 - | 185 184 0.39% | 0,87 0,29 205.61% | 229 202 13.64% | 803 634 26.67% | 1 207 1 130 6.78% |
|
EBITDA Million SEK | Released Forecast Spread | -132 -175 24.33% | -28,0 -29,5 5.23% | -380 -332 -14.26% | -524 -519 -1.11% | -422 -497 15.07% | -373 -472 20.91% |
|
EBIT Million SEK | Released Forecast Spread | -132 -175 24.3% | -28,0 -29,5 5.17% | -380 -353 -7.45% | -524 -533 1.66% | -422 -520 18.85% | -373 -495 24.64% |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -132 -175 24.33% | -32,5 -15,7 -107.54% | -436 -373 -17% | -513 -536 4.21% | -409 -493 16.97% | -457 -531 13.94% |
|
Net income Million SEK | Released Forecast Spread | -132 -175 24.36% | -32,6 -15,7 -108.03% | -433 -373 -16.26% | -500 -540 7.43% | -412 -469 12.15% | -466 -516 9.67% |
|
EPS SEK | Released Forecast Spread | -3,75 -4,30 12.79% | -0,88 -0,41 -114.63% | -9,66 -7,14 -35.29% | -9,84 -9,24 -6.49% | -7,78 -7,90 1.54% | -8,69 -9,01 3.58% |
| Announcement Date | 07/02/19 | 14/02/20 | 18/02/21 | 24/02/22 | 23/02/23 | 21/02/24 |
Quarterly results
| Fiscal Period | December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 198 0,00 - | 31,2 0,00 - | 49,7 49,2 1.14% | 64,0 78,3 -18.23% | 260 137 89.79% | 429 204 110.27% | 191 232 -17.52% | 269 286 -5.77% | 295 331 -10.89% | 452 386 16.84% | 383 | 435 | 516 | 622 |
|
EBITDA Million SEK | Released Forecast Spread | 7,86 -179 104.38% | -222 -225 1.18% | -208 -233 10.55% | -210 -251 16.39% | -36,2 -181 80.01% | 32,5 -87,8 137% | -180 -137 -31.14% | -75,2 -111 32.17% | -160 -60,0 -165.84% | 41,8 -77,2 154.13% | -59,9 | -1,93 | 69,9 | 186 |
|
EBIT Million SEK | Released Forecast Spread | 7,86 -185 104.26% | -222 -240 7.35% | -208 -252 17.39% | -210 -241 12.92% | -36,2 -219 83.47% | 32,5 -118 127.57% | -180 -135 -33.64% | -75,2 -105 28.63% | -160 -68,0 -134.58% | 41,8 -77,2 154.1% | -31,6 | -1,91 | 51,7 | 151 |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | 6,48 -194 103.35% | -218 -262 16.76% | -211 -270 21.71% | -192 -243 21.05% | -16,0 -227 92.97% | 10,1 -126 108.01% | -208 -148 -40.79% | -70,7 -131 45.97% | -164 -79,7 -105.8% | -14,3 -100 85.79% | -45,6 | -31,6 | -1,64 | 59,1 |
|
Net income Million SEK | Released Forecast Spread | 10,8 -191 105.67% | -219 -248 11.59% | -207 -257 19.36% | -192 -243 20.74% | -9,11 -226 95.97% | -3,68 -124 97.04% | -188 -138 -35.8% | -91,9 -119 22.94% | -168 -77,7 -116.6% | -18,4 -100 81.7% | -47,2 | -33,4 | -3,45 | 57,2 |
|
EPS SEK | Released Forecast Spread | -3,62 -4,94 26.67% | -0,17 -2,99 94.32% | -0,07 -1,71 95.9% | -3,49 -1,70 -105.21% | -1,71 -3,07 44.25% | -3,14 -0,76 -313.87% | -0,34 -1,70 79.95% | -1,06 | -0,08 | 1,22 | 3,48 | |||
| Announcement Date | 18/11/21 | 24/02/22 | 18/05/22 | 18/08/22 | 14/11/22 | 23/02/23 | 16/05/23 | 17/08/23 | 07/11/23 | 21/02/24 | - | - | - | - |
More events
Past sector events for Calliditas Therapeutics AB
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CALTX Stock
- Calendar Calliditas Therapeutics AB
